Medifast (NYSE:MED) changed 2.34% to recent value of $54.75. The stock transacted 399840 shares during most recent day however it has an average volume of 309.00K shares. It spotted trading -65.65% off 52-week high price. On the other end, the stock has been noted 11.67% away from the low price over the last 52-weeks.
On March 19,2020, Medifast (NYSE:MED) the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, disclosed that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.13 per share is payable on May 6, 2020 to stockholders of record as of the close of business on March 31, 2020.
Medifast expects to maintain a program of paying dividends on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the company’s Board of Directors, who will evaluate the company’s dividend program from time to time based on factors that it deems relevant.
MED has a gross margin of 75.20% and an operating margin of 12.80% while its profit margin remained 10.90% for the last 12 months. Its earnings per share (EPS) expected to touch remained 39.20% for this year while earning per share for the next 5-years is expected to reach at 20.00%.
The company has 11.43M of outstanding shares and 11.22M shares were floated in the market. According to the most recent quarter its current ratio was 1.9 that represents company’s ability to meet its current financial obligations. The price moved ahead of -28.06% from the mean of 20 days, -41.72% from mean of 50 days SMA and performed -46.89% from mean of 200 days price. Company’s performance for the week was -20.08%, -46.03% for month and YTD performance remained -50.04%.
Shawn Harris is a Master’s in Business Administration by education. After completing his post-graduation, Shawn jumped the journalism bandwagon as a freelance journalist. Soon after that he landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor. As an avid day trader, Shawn is a master of technical analysis and writes tirelessly on how stocks are trading. He has extensive knowledge in technical analysis & news writing.